First Time Loading...

Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 178.47 USD 0.48%
Updated: Apr 19, 2024

Intrinsic Value

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. [ Read More ]

The intrinsic value of one RMD stock under the Base Case scenario is 163.79 USD. Compared to the current market price of 178.47 USD, Resmed Inc is Overvalued by 8%.

Key Points:
RMD Intrinsic Value
Base Case
163.79 USD
Overvaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Resmed Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RMD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Resmed Inc

Provide an overview of the primary business activities
of Resmed Inc.

What unique competitive advantages
does Resmed Inc hold over its rivals?

What risks and challenges
does Resmed Inc face in the near future?

Has there been any significant insider trading activity
in Resmed Inc recently?

Summarize the latest earnings call
of Resmed Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Resmed Inc.

Provide P/S
for Resmed Inc.

Provide P/E
for Resmed Inc.

Provide P/OCF
for Resmed Inc.

Provide P/FCFE
for Resmed Inc.

Provide P/B
for Resmed Inc.

Provide EV/S
for Resmed Inc.

Provide EV/GP
for Resmed Inc.

Provide EV/EBITDA
for Resmed Inc.

Provide EV/EBIT
for Resmed Inc.

Provide EV/OCF
for Resmed Inc.

Provide EV/FCFF
for Resmed Inc.

Provide EV/IC
for Resmed Inc.

Show me price targets
for Resmed Inc made by professional analysts.

What are the Revenue projections
for Resmed Inc?

How accurate were the past Revenue estimates
for Resmed Inc?

What are the Net Income projections
for Resmed Inc?

How accurate were the past Net Income estimates
for Resmed Inc?

What are the EPS projections
for Resmed Inc?

How accurate were the past EPS estimates
for Resmed Inc?

What are the EBIT projections
for Resmed Inc?

How accurate were the past EBIT estimates
for Resmed Inc?

Compare the revenue forecasts
for Resmed Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Resmed Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Resmed Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Resmed Inc compared to its peers.

Compare the P/E ratios
of Resmed Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Resmed Inc with its peers.

Analyze the financial leverage
of Resmed Inc compared to its main competitors.

Show all profitability ratios
for Resmed Inc.

Provide ROE
for Resmed Inc.

Provide ROA
for Resmed Inc.

Provide ROIC
for Resmed Inc.

Provide ROCE
for Resmed Inc.

Provide Gross Margin
for Resmed Inc.

Provide Operating Margin
for Resmed Inc.

Provide Net Margin
for Resmed Inc.

Provide FCF Margin
for Resmed Inc.

Show all solvency ratios
for Resmed Inc.

Provide D/E Ratio
for Resmed Inc.

Provide D/A Ratio
for Resmed Inc.

Provide Interest Coverage Ratio
for Resmed Inc.

Provide Altman Z-Score Ratio
for Resmed Inc.

Provide Quick Ratio
for Resmed Inc.

Provide Current Ratio
for Resmed Inc.

Provide Cash Ratio
for Resmed Inc.

What is the historical Revenue growth
over the last 5 years for Resmed Inc?

What is the historical Net Income growth
over the last 5 years for Resmed Inc?

What is the current Free Cash Flow
of Resmed Inc?

Financials

Balance Sheet Decomposition
Resmed Inc

Current Assets 2.4B
Cash & Short-Term Investments 210.2m
Receivables 764.3m
Other Current Assets 1.4B
Non-Current Assets 4.5B
Long-Term Investments 66.1m
PP&E 705.2m
Intangibles 3.4B
Other Non-Current Assets 365.7m
Current Liabilities 764.1m
Accounts Payable 202.4m
Accrued Liabilities 356.2m
Other Current Liabilities 205.5m
Non-Current Liabilities 1.7B
Long-Term Debt 1.2B
Other Non-Current Liabilities 442.4m
Efficiency

Earnings Waterfall
Resmed Inc

Revenue
4.5B USD
Cost of Revenue
-2B USD
Gross Profit
2.5B USD
Operating Expenses
-1.3B USD
Operating Income
1.2B USD
Other Expenses
-324.8m USD
Net Income
890.4m USD

Free Cash Flow Analysis
Resmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

RMD Profitability Score
Profitability Due Diligence

Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Operating Income
66/100
Profitability
Score

Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

RMD Solvency Score
Solvency Due Diligence

Resmed Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Short-Term Solvency
81/100
Solvency
Score

Resmed Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RMD Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMD is 206.73 USD with a low forecast of 165.64 USD and a high forecast of 238.35 USD.

Lowest
Price Target
165.64 USD
7% Downside
Average
Price Target
206.73 USD
16% Upside
Highest
Price Target
238.35 USD
34% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RMD Price
Resmed Inc

1M 1M
-8%
6M 6M
+25%
1Y 1Y
-20%
3Y 3Y
-12%
5Y 5Y
+85%
10Y 10Y
+329%
Annual Price Range
178.47
52w Low
134.65
52w High
240.5
Price Metrics
Average Annual Return 24.74%
Standard Deviation of Annual Returns 32.26%
Max Drawdown -54%
Shares Statistics
Market Capitalization 26.2B USD
Shares Outstanding 147 088 992
Percentage of Shares Shorted 6.12%

RMD Return Decomposition
Main factors of price return

What is price return decomposition?

RMD News

Other Videos

Company Profile

Resmed Inc Logo
Resmed Inc

Country

United States of America

Industry

Health Care

Market Cap

26.2B USD

Dividend Yield

1.07%

Description

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 7,970 full-time employees. The firm is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The firm operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The firm's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Contact

CALIFORNIA
San Diego
9001 Spectrum Center Blvd
+18587462400.0
https://www.resmed.com/

IPO

1995-06-01

Employees

7 970

Officers

CEO & Chairman
Mr. Michael J. Farrell BE, MBA, SM
Founder, Chair Emeritus & Director
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD
Chief Financial Officer
Mr. Brett A. Sandercock
Special Advisor
Mr. Robert A. Douglas
Chief Commercial Officer - SaaS
Mr. Kaushik Ghoshal
Chief Investor Relations Officer
Ms. Amy Wakeham
Show More
Chief Legal Officer
Mr. Michael J. Rider
Chief Compliance Officer
Mr. Jim Ellis
Chief Marketing Officer
Ms. Yvonne-Katrin Pucknat
Chief People Officer
Ms. Vered Keisar
Show Less

See Also

Discover More
What is the Intrinsic Value of one RMD stock?

The intrinsic value of one RMD stock under the Base Case scenario is 163.79 USD.

Is RMD stock undervalued or overvalued?

Compared to the current market price of 178.47 USD, Resmed Inc is Overvalued by 8%.